Public Domain from pixabay
(BPT) – This post is sponsored by Eisai Inc.
Approximately two-thirds of adults in this country are overweight or obese. This extra weight may pose life-threatening health risks including diabetes, heart disease, stroke and certain cancers. For an overweight person, losing even 5 percent of their weight can be meaningful. While the idea of losing weight may feel overwhelming, beginning the journey means starting with small steps.
An important place to start is with healthy eating. Often times, go-to food favorites are high in fat, sugar, starch and sodium. Eating large portions of such foods can hinder weight loss and lead to obesity and related health risks. Reducing portions can help cut calories, and there are ways of adjusting favorite recipes to add healthy ingredients without skimping on flavor.
For example, try the Oven-Fried Fish & Chips recipe below for a lighter take on a popular dish. To cut the calories in half and reduce the fat, this recipe calls for coating the delicate fish in a crispy cornflake crust before baking it along with sliced potatoes.
When trying to lose weight, physical activity is also an important factor. Consider finding ways to work small changes into your daily routine; taking the stairs instead of the elevator, or parking on the far side of the lot are great ways to get started.
Some people still struggle with weight loss despite reducing calorie intake and undertaking an exercise routine. For those looking to add to their weight-loss regimen of a reduced-calorie diet and increased physical activity, BELVIQ® (lorcaserin HCl) CIV is an FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some overweight (Body Mass Index [BMI] =27 kg/m²) adults with a weight-related medical problem, or obese (BMI =30 kg/m²) adults, lose weight and keep it off. It is not known if BELVIQ when taken with other prescription, over-the-counter, or herbal weight-loss products is safe and effective.
BELVIQ was tested in three major clinical studies–two trials in adults without type 2 diabetes mellitus and one study in adults with type 2 diabetes mellitus. All three studies evaluated the effect of BELVIQ 10 mg twice daily compared to diet and exercise alone. The combined results of the two studies in patients without diabetes showed that almost half of patients (47.1%) taking BELVIQ lost 5% or more of their body weight after one year of treatment, and some (22.4%) lost 10% or more of their body weight after one year of treatment. In the study that enrolled overweight men and women with type 2 diabetes, results showed that more than a third of people taking BELVIQ with diet and exercise (37.5%) lost 5% or more of their body weight, compared with those using diet and exercise alone (16.1%). In the same study, the BELVIQ group showed significant improvements in blood sugar levels, compared with those using diet and exercise alone.
People taking BELVIQ with diet and exercise also had significant improvements in their blood pressure and cholesterol levels, compared to those using diet and exercise alone. It is not known if BELVIQ changes your risk of heart problems, stroke, or death due to heart problems or stroke.
Those looking to manage their weight while overcoming challenges to become healthy can learn more and become inspired by others through BELVIQ® VOICESTM at www.belviqvoices.com, an online community featuring real life weight loss journeys of patients living with obesity. Meant to inspire and encourage honest, open conversation with health care providers, BELVIQ VOICES shares the true stories of patients who have struggled with weight loss. The site also provides information about the obesity epidemic, associated health risk factors and the need for action. Patients who have tried BELVIQ and want to share their own weight loss story can email email@example.com.
Oven-Fried Fish & Chips
Prep time: 25 mins
Cook Time: 45 mins
Canola or olive oil cooking spray
1 1/2 pounds russet potatoes, scrubbed and cut into 1/4-inch-thick wedges
4 teaspoons canola oil
1 1/2 teaspoons Cajun or Creole seasoning, divided
2 cups cornflakes
1/4 cup all-purpose flour
1/4 teaspoon salt
2 large egg whites, beaten
1 pound cod or haddock, cut into 4 portions
- Position racks in upper and lower third of oven; preheat to 425°F. Coat a large baking sheet with cooking spray. Set a wire rack on another large baking sheet; coat with cooking spray.
- Place potatoes in a colander. Thoroughly rinse with cold water, then pat dry completely with paper towels. Toss the potatoes, oil and 3/4 teaspoon Cajun (or Creole) seasoning in a large bowl. Spread on the baking sheet without the rack. Bake on the lower oven rack, turning every 10 minutes, until tender and golden, 30 to 35 minutes.
- Meanwhile, coarsely grind cornflakes in a food processor or blender or crush in a sealable plastic bag. Transfer to a shallow dish. Place flour, the remaining 3/4 teaspoon Cajun (or Creole) seasoning and salt in another shallow dish and egg whites in a third shallow dish. Dredge fish in the flour mixture, dip it in egg white and then coat all sides with the ground cornflakes. Place on the prepared wire rack. Coat both sides of the breaded fish with cooking spray.
- Bake the fish on the upper oven rack until opaque in the center and the breading is golden brown and crisp, about 20 minutes.
325 calories/per serving
Saturated Fat 0g
Monounsaturated Fat 3g
Recipe from EatingWell.com © Meredith corporation. All rights reserved. Used with permission.
Important Safety Information about BELVIQ®
Pregnancy: Do not take BELVIQ if you are pregnant or planning to become pregnant, as weight loss offers no potential benefit during pregnancy and BELVIQ may harm your unborn baby.
Serotonin Syndrome or Neuroleptic Malignant Syndrome (NMS)-like reactions: Before using BELVIQ, tell your doctor about all the medicines you take, especially medicines that treat depression, migraines, mental problems, or the common cold. These medicines may cause serious or life-threatening side effects if taken with BELVIQ. Call your doctor right away if you experience agitation, hallucinations, confusion, or other changes in mental status; coordination problems; uncontrolled muscle spasms; muscle twitching; restlessness; racing or fast heartbeat; high or low blood pressure; sweating; fever; nausea; vomiting; diarrhea; or stiff muscles.
Valvular heart disease: Some people taking medicines like BELVIQ have had heart valve problems. Call your doctor right away if you experience trouble breathing; swelling of the arms, legs, ankles, or feet; dizziness, fatigue, or weakness that will not go away; or fast or irregular heartbeat. Before taking BELVIQ, tell your doctor if you have or have had heart problems.
Changes in attention or memory: BELVIQ may slow your thinking. You should not drive a car or operate heavy equipment until you know how BELVIQ affects you.
Mental problems: Taking too much BELVIQ may cause hallucinations, a feeling of being high or in a very good mood, or feelings of standing outside your body.
Depression or thoughts of suicide: Call your doctor right away if you notice any mental changes, especially sudden changes in your mood, behaviors, thoughts, or feelings, or if you have depression or thoughts of suicide.
Low blood sugar: Weight loss can cause low blood sugar in people taking medicines for type 2 diabetes, such as insulin or sulfonylureas. Blood sugar levels should be checked before and while taking BELVIQ. Changes to diabetes medication may be needed if low blood sugar develops.
Painful erections: If you have an erection lasting more than 4 hours while on BELVIQ, stop taking BELVIQ and call your doctor or go to the nearest emergency room right away.
Slow heartbeat: BELVIQ may cause your heart to beat slower.
Decreases in blood cell count: BELVIQ may cause your red and white blood cell counts to decrease.
Increase in prolactin: BELVIQ may increase the amount of a hormone called prolactin. Tell your doctor if your breasts begin to make milk or a milky fluid, or if you are a male and your breasts increase in size.
Most common side effects in patients without diabetes: Headache, dizziness, fatigue, nausea, dry mouth, and constipation.
Most common side effects in patients with diabetes: Low blood sugar, headache, back pain, cough, and fatigue.
Nursing: BELVIQ should not be taken while breastfeeding.
Drug interactions: Before taking BELVIQ, tell your doctor if you take medicines for depression, migraines, or other medical conditions, such as: triptans; medicines used to treat mood, anxiety, psychotic or thought disorders, including tricyclics, lithium, selective serotonin reuptake inhibitors, selective serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors, or antipsychotics; cabergoline; linezolid (an antibiotic); tramadol; dextromethorphan (an over-the-counter (OTC) common cold/cough medicine); OTC supplements such as tryptophan or St. John’s Wort; or erectile dysfunction medicines.
BELVIQ is a federally controlled substance (CIV) because it may be abused or lead to drug dependence.
For more information about BELVIQ, click here for the full Product Information or visit www.Belviq.com.
BELVIQ® is a registered trademark of Arena Pharmaceuticals GmbH. VOICES™ is a trademark of Eisai Inc.
For more information on weight loss and patients’ experiences, visit www.BELVIQVoices.com.